146 related articles for article (PubMed ID: 28743126)
1. Frontal Cortex and Hippocampal γ-Secretase Activating Protein Levels in Prodromal Alzheimer Disease.
Perez SE; Nadeem M; Malek-Ahmadi MH; He B; Mufson EJ
Neurodegener Dis; 2017; 17(6):235-241. PubMed ID: 28743126
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains.
Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
Neuropathol Appl Neurobiol; 2012 Apr; 38(2):132-41. PubMed ID: 21718343
[TBL] [Abstract][Full Text] [Related]
3. Gamma secretase-activating protein is a substrate for caspase-3: implications for Alzheimer's disease.
Chu J; Li JG; Joshi YB; Giannopoulos PF; Hoffman NE; Madesh M; Praticò D
Biol Psychiatry; 2015 Apr; 77(8):720-8. PubMed ID: 25052851
[TBL] [Abstract][Full Text] [Related]
4. Degradation of gamma secretase activating protein by the ubiquitin-proteasome pathway.
Chu J; Li JG; Hoffman NE; Madesh M; Praticò D
J Neurochem; 2015 May; 133(3):432-9. PubMed ID: 25533523
[TBL] [Abstract][Full Text] [Related]
5. Modulation of amyloid precursor protein cleavage by γ-secretase activating protein through phase separation.
Jin C; Wang J; Wang Y; Jia B; Guo X; Yang G; Xu P; Greengard P; Zhou R; Shi Y
Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2122292119. PubMed ID: 35298330
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
7. Increased γ-secretase activity in idiopathic normal pressure hydrocephalus patients with β-amyloid pathology.
Laiterä T; Sarajärvi T; Haapasalo A; Puli L; Kauppinen T; Mäkinen P; Rauramaa T; Tanila H; Jääskeläinen JE; Alafuzoff I; Soininen H; Leinonen V; Hiltunen M
PLoS One; 2014; 9(4):e93717. PubMed ID: 24699723
[TBL] [Abstract][Full Text] [Related]
8. GSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer's disease.
Xu P; Chang JC; Zhou X; Wang W; Bamkole M; Wong E; Bettayeb K; Jiang LL; Huang T; Luo W; Xu H; Nairn AC; Flajolet M; Ip NY; Li YM; Greengard P
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34156424
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
10. Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
J Alzheimers Dis; 2018; 62(1):115-131. PubMed ID: 29439356
[TBL] [Abstract][Full Text] [Related]
11. GSAP modulates γ-secretase specificity by inducing conformational change in PS1.
Wong E; Liao GP; Chang JC; Xu P; Li YM; Greengard P
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6385-6390. PubMed ID: 30850537
[TBL] [Abstract][Full Text] [Related]
12. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
13. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Common GSAP promoter variant contributes to Alzheimer's disease liability.
Zhu M; Tao Y; He Q; Gao H; Song F; Sun YM; Li HL; Wu ZY; Saffen D
Neurobiol Aging; 2014 Nov; 35(11):2656.e1-2656.e7. PubMed ID: 25037285
[TBL] [Abstract][Full Text] [Related]
16. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
17. Tracing the GSAP-APP C-99 Interaction Site in the β-Amyloid Pathway Leading to Alzheimer's Disease.
Angira D; Chikhale R; Mehta K; Bryce RA; Thiruvenkatam V
ACS Chem Neurosci; 2019 Aug; 10(8):3868-3879. PubMed ID: 31299145
[TBL] [Abstract][Full Text] [Related]
18. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
19. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.
Giannakopoulos P; Herrmann FR; Bussière T; Bouras C; Kövari E; Perl DP; Morrison JH; Gold G; Hof PR
Neurology; 2003 May; 60(9):1495-500. PubMed ID: 12743238
[TBL] [Abstract][Full Text] [Related]
20. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F
J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
